Meet our dedicated Board of Directors, a group of experienced leaders committed to driving innovation and excellence in pharmaceutical research, ensuring our company’s mission to improve global health and deliver life-changing treatments.
Board-certified MD (Anesthesiology and Intensive Care) and DDS, Karolinska Institutet
Associate Professor and PhD in Physiology, Karolinska Institutet
Experience
Executive VP Global Medicines Development, Global Head Clinical Development, Global Therapy Area Head, and CEO, AstraZeneca AB Sweden.
Director and Chairman of the board, Karolinska university Hospital
Other assignments
Chairman/Non-Executive Board member of AnaMar AB, Alligator Bioscience AB, Elypta AB, Flerie Invest AB, Mereo BioPharma Group Plc, and Xspray Pharma AB
B.S and M.S. in Control and Instrumentation Engineering from Seoul National University
Experience
Managing Director of Investments at Korea Investment Partners (KIP)
Head of Korea Investment Partners’ US office based in Silicon Valley
18 years of industrial experiences in diverse area and companies in IT including Samsung Electronics, Dasan networks, as well as successful venture startups including Neomtel and Polidigm
Other assignments
Board member of Prokarium Ltd, Enlivex, Geneos Therepeutics, and PDC*line Pharma
